TY - JOUR T1 - Symptom-level genetic modelling identifies novel risk loci and unravels the shared genetic architecture of anxiety and depression JF - medRxiv DO - 10.1101/2020.04.08.20057653 SP - 2020.04.08.20057653 AU - Jackson G. Thorp AU - Adrian I. Campos AU - Andrew D. Grotzinger AU - Zachary Gerring AU - Jiyuan An AU - Jue-Sheng Ong AU - Wei Wang AU - 23andMe Research Team AU - Suyash Shringarpure AU - Enda M. Byrne AU - Stuart MacGregor AU - Nicholas G. Martin AU - Sarah E. Medland AU - Christel M. Middeldorp AU - Eske M. Derks Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/14/2020.04.08.20057653.abstract N2 - Depression and anxiety are highly prevalent and comorbid psychiatric traits that cause considerable burden worldwide. Previous studies have revealed substantial genetic overlap between depression, anxiety, and a closely related personality trait – neuroticism. Here, we use factor analysis and genomic structural equation modelling (Genomic SEM) to investigate the genetic factor structure underlying 28 items assessing depression, anxiety and neuroticism. Symptoms of depression and anxiety loaded on two distinct, although genetically correlated factors, while neuroticism items were partitioned between them. We leveraged this factor structure to conduct multivariate genome-wide association analyses on latent factors of anxiety symptoms and depressive symptoms, using data from over 400,000 individuals in the UK Biobank. We identified 89 independent variants for the depressive factor (61 genomic loci, 29 novel) and 102 independent variants for the anxiety factor (73 loci, 71 novels). Of these variants, 72% and 78%, respectively, replicated in an independent 23andMe cohort of ∼1.9 million individuals with self-reported diagnosis of depression (634,037 cases) and anxiety (624,615 cases). A pairwise GWAS analysis revealed substantial genetic overlap between anxiety and depression but also showed trait-specific genetic influences; e.g. genomic regions specific to depressive symptoms were associated with hypertriglyceridemia, while regions specific to anxiety symptoms were linked to blood pressure phenotypes. The substantial genetic overlap between the two traits was further evidenced by a lack of trait-specificity in polygenic prediction of depressive and anxiety symptoms. Our results provide novel insight into the genetic architecture of depression and anxiety and comorbidity between them.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was conducted using the UK Biobank Resource (application number 25331). NGM received funding from the Australian National Health & Medical Research Council (NHMRC) to conduct surveys in the Australian Twin Registry. SM is supported by an NHMRC Fellowship.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSummary statistics will be made publicly available upon publication ER -